# Pharmacokinetics/Pharmacodynamics (PK/PD) of Cangrelor

> **NCT00102674** · PHASE1 · COMPLETED · sponsor: **The Medicines Company** · enrollment: 40 (—)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** cangrelor

## Key facts

- **NCT ID:** NCT00102674
- **Lead sponsor:** The Medicines Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** —
- **Final completion:** 2005-05
- **Target enrollment:** 40 (—)
- **Last updated:** 2011-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00102674

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00102674, "Pharmacokinetics/Pharmacodynamics (PK/PD) of Cangrelor". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00102674. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*